FDA approves self-collection cervical cancer kits from Roche and BD for patient use.

The FDA has approved self-collection kits for cervical cancer screenings, allowing patients to collect their own samples. The kits, from Roche and BD, are similar to traditional Pap smears in effectiveness and aim to improve comfort levels and accessibility for women who find traditional screenings uncomfortable or traumatizing. Insurance coverage for the tests is currently unclear.

August 16, 2024
4 Articles

Further Reading